Biokinetic models for the behavior of carbon-14 from labelled compounds in the human body: Can a single generic model be justified?

Radiation Protection Dosimetry

Volumn 108, Issue 3, 2004, Pages 187-202

  Taylor, David M ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID DERIVATIVE; ALANINE; BARIUM DERIVATIVE; BENZENE; BICARBONATE; CARBON 14; CARBON MONOXIDE; CARBONIC ACID DERIVATIVE; CHOLESTEROL; CORTICOSTERONE; DEXLOXIGLUMIDE; ESTRADIOL; ESTRONE DERIVATIVE; GLUCOSE; GLYCINE; GLYCOCHOLIC ACID; HYDROCORTISONE; INULIN; METHANE; METHANOL; MORPHOLINE DERIVATIVE; NITROBENZENE; PENTETIC ACID; POTASSIUM CYANIDE; TESTOSTERONE; THYMIDINE; TRIOLEIN; UNINDEXED DRUG; UREA; XYLOSE; CARBON; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

BIOASSAY; CALCULATION; CHEMICAL COMPOSITION; CONSTANTS AND COEFFICIENTS; CONTROLLED STUDY; DOSE RESPONSE; DOSIMETRY; DRUG ABSORPTION; DRUG ELIMINATION; DRUG HALF LIFE; HUMAN; ISOTOPE LABELING; MATHEMATICAL MODEL; NONHUMAN; PRACTICE GUIDELINE; PROCESS MODEL; PUBLICATION; RADIATION DOSE; RADIATION PROTECTION; RAT; REVIEW; ARTICLE; BIOLOGICAL MODEL; BODY BURDEN; COMPARATIVE STUDY; COMPUTER SIMULATION; EVALUATION; INTERNATIONAL COOPERATION; KINETICS; METHODOLOGY; RADIOMETRY; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; WHOLE BODY COUNTING;

BODY BURDEN; CARBON RADIOISOTOPES; COMPUTER SIMULATION; HUMANS; INTERNATIONALITY; KINETICS; MODELS, BIOLOGICAL; RADIATION DOSAGE; RADIATION PROTECTION; RADIOMETRY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; WHOLE-BODY COUNTING;

EID: 1842419591     PISSN: 01448420     EISSN: None     Source Type: Journal    
DOI: 10.1093/rpd/nch027     Document Type: Review

References (53)

1. 14C-DTPA in human volunteers after inhalation or intravenous injection. Health Phys. 44, 45-52 (1981).
2. 2 in long-term studies of fat metabolism. Appl. Radiat. Isot. 47, 417-422 (1996).
3. International Commission on Radiological Protection. Limits for intakes of radionuclides by workers: Part 3. ICRP Publication 30. Ann. ICRP 6(2/3), 4-9 (1981).
4. International Commission on Radiological Protection. Age-dependent doses to members of the public from intakes of radionuclides: Part 1. ICRP Publication 56. Ann. ICRP 20(2), 21-23 (1989).
5. International Commission on Radiological Protection. Dose coefficients for intakes of radionuclides by workers. ICRP Publication 68. Ann. ICRP 24(4), 1-84 (1994).
6. 14C internal dosimetry models and their implementation in the GENMOD-PC code. Health Phys. 81(3), 289-301 (2001).
7. International Commission on Radiological Protection. Report of the task group on reference man. ICRP Publication 23 (Oxford: Pergamon Press) (1975).
8. International Commission on Radiological Protection. Doses to patients ftom radiopharmaceuticals. ICRP Publication 53. Ann. ICRP 18(1-4), 55-58 (1987).
9. International Commission on Radiological Protection. Radiation doses to patients from radiopharmaceuticals. Addendum to ICRP 53. Publication 80. Ann. ICRP 28(3) (1998).
10. International Commission on Radiological Protection. Age-dependent doses to members of the public from intakes of radionuclides: Part 5. compilation of ingestion and inhalation dose coefficients. ICRP Publication 72. Ann. ICRP 26(1) 15 and 44 (1996).
11. 14C. Health Phys. 70, 418-424 (1996).
12. Crawley, F. E. H. and Haines, J. W. The metabolism and dosimetry of carbon-14 labelled compounds. In: National Radiological Protection Board: Annual Research and Development Report 1978. NRPB R&D3, June (London: Her Majesty's Stationery Office) (1979).
13. Crawley, F. E. H. and Goddard, E. A. Internal dose from carbon-14 labelled compounds. The metabolism of carbon-14 labelled potassium cyanide in the rat. Health Phys. 32, 135-142 (1977).
14. Crawley, F. E. H. and Haines, J. W. Further studies on the metabolism and dosimetry of carbon-14 labelled compounds. In: National Radiological Protection Board: Annual Research and Development Report 1977. NRPB R&D2, April (London: Her Majesty's Stationery Office (1978).
15. Crawley, F. E. H. The metabolism and dosimetry of carbon-14 labelled compounds. In: Proceedings of Fourth International Congress of the International Radiation Protection Association, Paris, April, 2 pp. 425-428 (1977).
16. Stabin, M. G. MIRDOSE: Personal computer software for internal dose assessment in nuclear medicine. J. Nucl. Med. 37, 538-546 (1996).
17. International Commission on Radiological Protection. Human respiratory tract model for radiological protection. ICRP Publication 66. Ann. ICRP 24(1-3) (1994).
18. - in normal adult males. J. Nucl. Med. 11, 711-715 (1977).
19. Stubbs, J. B. and Marshall, B. J. Radiation estimates of the carbon-labelled urea breath test. J. Nucl. Med. 34, 821-825 (1993).
20. 14C and organically bound tritium dosimetry. Radiat. Prot. Dosim. 105, 189-192 (2003).
21. Whillans, D. W. and Johnson, J. R. Interpretation of urinary excretion rat data in the assessment of uptakes of carbon-14. In: Assessment of Radioactive Contamination in Man International Atomic Energy Agency, IAEA-SM-276/50, pp. 525-532 (1985).
22. Leggett, R. W. A biokinetic model for carbon dioxide and bicarbonate. Radiat. Prot. Dosim. 108, 203-213 (2004).
23. Leide-Svegborn, S., Stenström, K., Olofsson, M., Mattsson, S., Nilsson, L.-E., Nosslin, B., Pau, K., Johansson, L., Erlandsson, B., Hellborg, R. and Skog, G. Biokinetics and radiation doses for carbon-14 urea in adults and children undergoing the Helicobacter pylori breath test. Eur. J. Nucl. Med. 26, 573-580 (1999).
24. Malmendier, C. L., Delcrois, C. and Berman, M. Inter-relations in the oxidative metabolism of free fatty acids, glucose, and glycerol in normal and hyperlipemic patients. J. Clin. Invest. 54, 461-476 (1974).
25. 14 studies in carbohydrate metabolism I. The oxidation of glucose in normal human subjects. J. Biol. Chem. 211, 575-592 (1954).
26. 14 from uniformly labelled glucose into plasma triglycerides in normals and hyperglyceridemics. Metab. Clin. Exp. 11, 893-911 (1962).
27. Hirsch, J., Farquhar, J. W. Ahrens, E. H., Jr, Peterson, M. L. and Stoffel, W. Studies of adipose tissue in man. A microtechnic for sampling and analysis. Am. J. Physiol. 8, 499-511 (1960).
28. 14C-triolein. Eur. J. Nucl. Med. 6, 327-329 (1981).
29. 14C]oleate fat malabsorption breath test. Appl. Radiat. Isot. 58, 517-526 (2003).
30. 14C-labelled triolein, urea, glycocholic acid and xylose in man. Doctoral dissertation, University of Lund, ISBN 91-628-5316-3 (2002 ).
31. 2. J. Clin. Invest. 30, 73-76 (1951).
32. 2. Proc. Soc. Exp. Biol. Med. 88, 386-389 (1955).
33. 14 C]-alanine for human studies. Health Phys. 43, 561-565 (1982).
34. Hellman, L., Rosenfeld, R. S., Eidinoff, M. L., Fukushima, D. K., Gallagher, T. F., Wang, C.-I. and Adlersberg, D. Isotopic studies of plasma cholesterol of endogenous and exogenous origin. J. Clin. Invest. 34, 48-60 (1955).
35. Fukushima, D. K., Dobriner, K. and Gallagher, T. F. Studies with testosterone-d in normal men. J. Biol. Chem. 206, 845-861 (1954).
36. Fukushima, D. K., Bradlowe, H. L., Dobriner, K. and Gallagher, T. F. The fate of testosterone infused intravenously in man. J. Biol. Chem. 206, 863-874 (1954).
37. Beer, C. T. and Gallagher, T. F. Excretion of estrogen metabolites by humans. I. The fate of small doses of estrone and estradiol-17β. J. Biol. Chem. 214, 335-350 (1955a).
38. Beer, C. T. and Gallagher, T. F. Excretion of estrogen metabolites by humans. II. The fate of large doses of estradiol-17β after intramuscular and oral administration. J. Biol. Chem. 214, 351-364 (1955b).
39. 14-estradiol in women. J. Clin. Invest. 36, 1266-1278 (1957).
40. 14-corticosterone in man. J. Clin. Endocrinol. Metab. 16, 1291-1298 (1956).
41. 14 in man. J. Clin. Invest. 33, 1106-1115 (1954).
42. Feinendegen, L. E. Radiation problems infusion energy production. In: Radiation Research (Proceedings 6th International Congress of Radiation Research) Okada, S., Imamura, M., Terasima, T. and Yamaguchi, H., Eds. (Tokyo: Japan Association for Radiation Research) pp. 32-45 (1979).
43. Feinendegen, L. E. and Cronkite, E. P. Effect of microdistribution of radionuclides on recommended limits in radiation protection. Curr. Top. Rad. Res. Q. 12, 83-99 (1977).
44. Van der Borght, T., de Maight, S., Labur, D. Goethals, P., van Eijkeren, M. and Pauwels, S. Comparison of thymidine labelled in 2C ring position in human PET studies. Eur. J. Nucl. Med. 19, 578 (Abstr.) (1992).
45. 11C]thymidine. Br. J. Radiol. 67, 292-295 (1994).
46. Fell, T. P. Private communication to D. M. Taylor (2002).
47. Krins, A., Karcher, K., Noßke, D., Sahre, P. and Schönmuth, T. Determination of dose coefficients and urinary excretion function for inhalation of carbon-14-labelled benzene. Radiat. Prot. Dosim. 104(2), 139-152 (2003).
48. 14C-delmopinol in the healthy male volunteer. Xenobiotica 28 (1998).
49. Webber, C., Roth, A., Persiani, S., Peard, A. J., Makovec, F., Kapil, R. P., John, B. A., Holding, J. D., D'Amato, M., Cybulski, Z. R., Chasseaud, L. F. and Rovati, L. C. Pharmacokinetics and metabolism of the cholecystokinin antagonist dexloxiglumide in male human subjects. Xenobiotica 33, 625-641 (2003).
50. Takeda, H., Fuma, S., Miyamoto, K., Nishimura, Y. and Inaba, J. Biokinetics and dose estimations of radiocarbon in rats. Radiat. Prot. Dosim. 79, 169-174 (1998).
51. Richardson, R. B. and Dunford, D. W. A biochemical-based model for the dosimetry of dietary organically bound tritium - part 1. Health Phys. 85, 523-538 (2003).
52. Richardson, R. B. and Dunford, D. W. A biochemical-based model for the dosimetry of dietary organically bound tritium - Part 2. Health Phys. 85, 539-552 (2003).
53. Richardson, R. B. Barebones HCNO model. Personal communication to D. M. Taylor (2002).